Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3589463
Max Phase: Preclinical
Molecular Formula: C29H26N4O9S
Molecular Weight: 606.61
Molecule Type: Small molecule
Associated Items:
ID: ALA3589463
Max Phase: Preclinical
Molecular Formula: C29H26N4O9S
Molecular Weight: 606.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc([C@@H]2c3cc4c(cc3[C@@H](n3nnnc3S(=O)(=O)c3ccc(C)cc3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O
Standard InChI: InChI=1S/C29H26N4O9S/c1-14-4-6-16(7-5-14)43(36,37)29-30-31-32-33(29)26-18-11-21-20(41-13-42-21)10-17(18)24(25-19(26)12-40-28(25)35)15-8-22(38-2)27(34)23(9-15)39-3/h4-11,19,24-26,34H,12-13H2,1-3H3/t19-,24+,25-,26+/m0/s1
Standard InChI Key: HTOJSUKPYAXFHO-QNMIOERPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 606.61 | Molecular Weight (Monoisotopic): 606.1420 | AlogP: 2.79 | #Rotatable Bonds: 6 |
Polar Surface Area: 161.19 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.33 | CX Basic pKa: | CX LogP: 3.50 | CX LogD: 3.50 |
Aromatic Rings: 4 | Heavy Atoms: 43 | QED Weighted: 0.32 | Np Likeness Score: 0.00 |
1. Hyder I, Yedlapudi D, Kalivendi SV, Khazir J, Ismail T, Nalla N, Miryala S, Sampath Kumar HM.. (2015) Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds., 25 (14): [PMID:26022842] [10.1016/j.bmcl.2015.04.053] |
Source(1):